TRDA — Entrada Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Entrada Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	291	189	352	420	296
Net Total Receivables	—	—	5.88	3.68	1.18
Prepaid Expenses
Total Other Current Assets
Total Current Assets	299	210	370	440	306
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.26	33	92.7	82	67.8
Other Long Term Assets
Total Assets	306	252	469	526	377
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	6.72	22	159	39.5	24.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.12	39.5	227	97.6	71.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	299	213	242	429	306
Total Liabilities & Shareholders' Equity	306	252	469	526	377
Total Common Shares Outstanding